# FDA Inspection 1264098 - CSL Plasma Inc. - February 12, 2025

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/6f71a210-cb68-4bcf-a246-d876cb178f7b
Source feed: FDA_Inspections

> FDA Inspection 1264098 for CSL Plasma Inc. on February 12, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264098
- Company Name: CSL Plasma Inc.
- Inspection Date: 2025-02-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1264098 - 2025-02-12](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/4dcffe0e-45bc-462a-bb8f-b6e5934168b0)
- [FDA Inspection 1101680 - 2019-08-23](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/76857705-0fbd-4fd5-98a9-b1482d4c3313)
- [FDA Inspection 1016456 - 2017-06-14](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/63337bec-4bbf-4217-8825-52736d7e8a50)
- [FDA Inspection 934929 - 2015-07-17](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/90d34df1-fa68-4791-984f-44b2a75feedf)

Company: https://www.keypedia.com/companies/csl-plasma-inc/476820b2-f874-4375-adff-18c0a9bfed30

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d